Newcardio Inc is categorized under Electromedical Equipment in Princeton, NJ and active since 2004.
Newcardio Inc was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Electromedical Equipment business, which does work in the B2B market, and is classified as a Electromedical Equipment, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Dr Jess Emery Jones at the company’s single location by writing to 103 Carnegie Center # 300, Princeton, New Jersey NJ 08540 or by phoning (770) 267-2168. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Newcardio Inc |
| Contact Person: | Dr Jess Emery Jones |
| Address: | 103 Carnegie Center # 300, Princeton, New Jersey 08540 |
| Phone Number: | (770) 267-2168 |
| Website Address: | epfloors.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Electromedical Equipment |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Newcardio Inc was started in 2004 to provide professional Electromedical Equipment under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Dr Jess Emery Jones for inquiries that concern Newcardio Inc by calling the company number (770) 267-2168, as your correspondence is most welcome. Additionally, the physical location of the single location of Newcardio Inc can be found at the coordinates 40.323771,-74.645673 as well as the street address 103 Carnegie Center # 300 in Princeton, New Jersey 08540.
For its online presence, you may visit Newcardio Inc’s website at epfloors.com and engage with its social media outlets through on Twitter and on Facebook.